Search results - 97 results

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, clinical efficacy, and safety of prophylactic HPV vaccines in females. The assessment of ...

Guidelines for Independent Lot Release of Vaccines by Regulatory Authorities

BCG conditions consultation Control Countries criteria data Decision function guidance Guidelines health HPV IS IT Laboratories Lead marketing measurement national need ON PRODUCTS PROGRAM programme ...

Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands.

Cervical Diseases Uterine Cervical Neoplasms Abstract: AIMS: To document progress with human papillomavirus (HPV) vaccine introduction in three closely related European countries, one with organized (the ...

Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.

progress of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National ...

The challenges of organising cervical screening programmes in the 15 old member states of the European Union.

programmes commenced in Portugal and Spain. Introduction of new methods of prevention, such as HPV screening and prophylactic HPV vaccination, can reduce the burden further, but this will require a high level ...

International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention.

randomised controlled trials, comparing cytology with HPV-based cervical cancer screening, consistently show increased detection of high-grade cervical intraepithelial neoplasia (CIN) in the HPV-arm. These ...

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.

papillomavirus (HPV) DNA testing in the management of women with equivocal cervical cytological abnormalities, but not in case of low-grade lesions. We performed a meta-analysis including studies where the ...

Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.

the introduction of vaccination against human papillomaviruses (HPV) as a new strategy of combating cervical cancer, it is required to describe the baseline prevalence of HPV infection as well as the ...

Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.

therapeutic vaccines. One prophylactic quadrivalent vaccine using L1 virus-like particles (VLP) of HPV 6, 11, 16 and 18 is available on the European market since the end of 2006 and it is expected that a second ...

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

AND METHODS: A summary is given from recently published meta-analyses on three possible clinical applications of human papillomavirus (HPV)- DNA testing: triage of women with equivocal or low-grade ...

QR code

QR code for this page URL